Trial Profile
Observational Study GONAL-f Consort.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms GONAL-f CONSORT
- Sponsors Merck KGaA
- 17 Jan 2013 Actual initiation date changed from Feb 2011 to Jul 2011 as reported by ClinicalTrials.gov.
- 19 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Oct 2010 Planned end date changed from 1 May 2010 to 1 Feb 2011 as reported by ClinicalTrials.gov.